BIIB

BIIB Retained Earnings

$20.97BQuarterly · USD

Period ending:

BIIB FY Retained EarningsUSD
BIIB FY Retained Earnings1985-12-31: -$53.80M1986-12-31: -$82.00M1987-12-31: -$104.60M1988-12-31: -$105.80M1989-12-31: -$105.30M1990-12-31: -$103.40M1991-12-31: -$99.20M1992-12-31: -$60.90M1993-12-31: -$28.50M1994-12-31: -$33.36M1995-12-31: -$27.70M1996-12-31: $12.83M1997-12-31: $25.33M1998-12-31: $213.51M1999-12-31: $352.02M2000-12-31: $543.91M2001-12-31: $705.89M2002-12-31: $263.18M2003-12-31: -$611.92M2004-12-31: -$801.09M2005-12-31: -$1.02B2006-12-31: -$860.83M2007-12-31: -$352.17M2008-12-31: $270.18M2009-12-31: $1.07B2010-12-31: $1.87B2011-12-31: $3.11B2012-12-31: $4.49B2013-12-31: $6.35B2014-12-31: $9.28B2015-12-31: $12.21B2016-12-31: $15.07B2017-12-31: $15.81B2018-12-31: $16.26B2019-12-31: $16.46B2020-12-31: $13.98B2021-12-31: $13.91B2022-12-31: $16.47B2023-12-31: $17.63B2024-12-31: $19.26B2025-12-31: $20.55B$20.55B-$1.02B
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BIIB retained earnings history

Cumulative earnings retained in the business. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

Biogen Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
20,552,700,000
19,259,800,000
17,627,600,000
16,466,500,000
13,911,700,000
13,976,300,000
16,455,400,000
16,257,000,000
15,810,400,000
15,071,600,000
12,208,400,000
9,283,919,000
6,349,135,000
4,486,794,000
3,106,761,000
1,872,481,000
1,068,890,000
270,180,000
-352,169,000
-860,827,000
-1,021,644,000
-801,094,000
-611,921,000
263,176,000
705,893,000
543,913,000
352,016,000
213,507,000
25,327,000
12,831,000
-27,699,000
-33,359,000
-28,500,000
-60,900,000
-99,200,000
-103,400,000
-105,300,000
-105,800,000
-104,600,000
-82,000,000
-53,800,000

Compare retained earnings

All BIIB financial metrics · BIIB stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.